financetom
Business
financetom
/
Business
/
SunCoke Q3 net income beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SunCoke Q3 net income beats estimates
Nov 4, 2025 4:45 AM

Overview

* SunCoke Q3 net income and adjusted EBITDA beat analyst expectations despite yr/yr decline

* Company completed acquisition of Phoenix Global, contributing positively to Q3 results

* Updated 2025 guidance reflects Phoenix Global integration and coke sales deferral due to breach

Outlook

* SunCoke updates full-year 2025 Consolidated Adjusted EBITDA to $220 mln - $225 mln

* Company expects 2025 Domestic Coke production of approximately 3.9 mln tons

* SunCoke projects 2025 capital expenditures of approximately $70 mln

Result Drivers

* PHOENIX GLOBAL ACQUISITION - Acquisition of Phoenix Global contributed positively to Industrial Services segment results

* DOMESTIC COKE CHALLENGES - Unfavorable mix of contract and spot coke sales impacted Domestic Coke segment

* LOGISTICS VOLUME WEAKNESS - Logistics terminal volumes did not recover as expected due to weak market conditions

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Net Beat $22.20 $13.80

Income mln mln (2

Analysts

)

Q3 Beat $59.10 $54 mln

Adjusted mln (2

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the iron & steel peer group is "buy"

* Wall Street's median 12-month price target for SunCoke Energy Inc ( SXC ) is $12.00, about 31.3% above its November 3 closing price of $8.24

* The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 12 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Congo lawyers say received new evidence on Apple's minerals supply chain
Congo lawyers say received new evidence on Apple's minerals supply chain
May 22, 2024
PARIS, May 22 (Reuters) - International lawyers representing the government of the Democratic Republic of Congo said on Wednesday new evidence gathered from whistleblowers indicates that Apple ( AAPL ) is sourcing minerals from conflict areas in the east of the country. In a statement, the lawyers urged Apple ( AAPL ) to answer questions about its supply chain in...
Golden Ocean Group Q1 Adjusted Earnings, Revenue Grow
Golden Ocean Group Q1 Adjusted Earnings, Revenue Grow
May 22, 2024
05:40 AM EDT, 05/22/2024 (MT Newswires) -- Golden Ocean Group ( GOGL ) reported Q1 adjusted earnings Wednesday of $0.29 per diluted share, up from $0.03 a year earlier. Analysts polled by Capital IQ expected $0.30. Operating revenue for the quarter ended March 31 was $246.7 million, up from $196.5 million a year earlier. Comparable analyst estimates weren't available. Price:...
Update: Skyline Champion Fiscal Q4 Adjusted Earnings Declines While Sales Rise Less Than Forecast; Shares Drop Premarket
Update: Skyline Champion Fiscal Q4 Adjusted Earnings Declines While Sales Rise Less Than Forecast; Shares Drop Premarket
May 22, 2024
05:37 AM EDT, 05/22/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Skyline Champion ( SKY ) shares dropped 5.4% in premarket activity on Wednesday after the company reported a steeper-than-anticipated drop in earnings while sales grew slower than forecast during fiscal Q4. The company reported fiscal Q4 adjusted net income Tuesday of...
Bristol-Myers Squibb Invests in NeoPhore
Bristol-Myers Squibb Invests in NeoPhore
May 22, 2024
05:36 AM EDT, 05/22/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) participated in immuno-oncology company NeoPhore's oversubscribed series B financing extension round, the latter said Wednesday. NeoPhore did not disclose the financial value of Bristol-Myers Squibb's ( BMY ) investment but said the funding will allow it to explore novel biology associated with the DNA mismatch repair pathway in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved